Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study

[Background] As estimated by the World Health Organization, depressive disorders will be the leading contributor to the Global Burden of Disease by 2030. In light of this fact, we designed a study whose aim was to investigate whether the value placed on health-related quality of life (HRQoL) for a d...

Full description

Bibliographic Details
Main Authors: Laura Ulbrich, Christoph Kröger
Format: Article
Language:English
Published: PsychOpen GOLD/ Leibniz Institute for Psychology 2021-12-01
Series:Clinical Psychology in Europe
Subjects:
Online Access:https://cpe.psychopen.eu/index.php/cpe/article/view/3855
_version_ 1797972456809431040
author Laura Ulbrich
Christoph Kröger
author_facet Laura Ulbrich
Christoph Kröger
author_sort Laura Ulbrich
collection DOAJ
description [Background] As estimated by the World Health Organization, depressive disorders will be the leading contributor to the Global Burden of Disease by 2030. In light of this fact, we designed a study whose aim was to investigate whether the value placed on health-related quality of life (HRQoL) for a depressive disorder is higher in patients diagnosed with a major depressive disorder (MDD) compared to non-patients in a matched sample. [Method] We collected data on willingness to pay (WTP) for a total of four health-gain scenarios, which were presented to 18 outpatients diagnosed with a MDD versus 18 matched non-patient respondents with no symptoms of depression. Matching characteristics included age, income, level of education, and type of health insurance. Respondents were presented with different HRQoL scenarios in which they could choose to pay money to regain their initial health state through various treatment options (e.g., inpatient treatment, electroconvulsive therapy). To test whether the probability of stating a positive WTP differed significantly between the two samples, Fisher’s exact test was used. Differences regarding stated WTP between the samples were investigated using the Mann-Whitney U-test. [Results] For most of the health scenarios, the probability of stating a positive WTP did not differ between the two samples. However, patient respondents declared WTP values up to 7.4 times higher than those stated by matched non-patient respondents. [Conclusion] Although the perceived necessity to pay for mental-HRQoL gains did not differ between respondents with MDD and respondents with no symptoms of depression, patient respondents stated higher values.
first_indexed 2024-04-11T03:48:43Z
format Article
id doaj.art-8253bf4b8c964e9ca5789150e450702c
institution Directory Open Access Journal
issn 2625-3410
language English
last_indexed 2024-04-11T03:48:43Z
publishDate 2021-12-01
publisher PsychOpen GOLD/ Leibniz Institute for Psychology
record_format Article
series Clinical Psychology in Europe
spelling doaj.art-8253bf4b8c964e9ca5789150e450702c2023-01-02T02:18:46ZengPsychOpen GOLD/ Leibniz Institute for PsychologyClinical Psychology in Europe2625-34102021-12-013410.32872/cpe.3855cpe.3855Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay StudyLaura Ulbrich0https://orcid.org/0000-0002-5434-7355Christoph Kröger1Department of Psychology, University of Hildesheim, Hildesheim, GermanyDepartment of Psychology, University of Hildesheim, Hildesheim, Germany[Background] As estimated by the World Health Organization, depressive disorders will be the leading contributor to the Global Burden of Disease by 2030. In light of this fact, we designed a study whose aim was to investigate whether the value placed on health-related quality of life (HRQoL) for a depressive disorder is higher in patients diagnosed with a major depressive disorder (MDD) compared to non-patients in a matched sample. [Method] We collected data on willingness to pay (WTP) for a total of four health-gain scenarios, which were presented to 18 outpatients diagnosed with a MDD versus 18 matched non-patient respondents with no symptoms of depression. Matching characteristics included age, income, level of education, and type of health insurance. Respondents were presented with different HRQoL scenarios in which they could choose to pay money to regain their initial health state through various treatment options (e.g., inpatient treatment, electroconvulsive therapy). To test whether the probability of stating a positive WTP differed significantly between the two samples, Fisher’s exact test was used. Differences regarding stated WTP between the samples were investigated using the Mann-Whitney U-test. [Results] For most of the health scenarios, the probability of stating a positive WTP did not differ between the two samples. However, patient respondents declared WTP values up to 7.4 times higher than those stated by matched non-patient respondents. [Conclusion] Although the perceived necessity to pay for mental-HRQoL gains did not differ between respondents with MDD and respondents with no symptoms of depression, patient respondents stated higher values.https://cpe.psychopen.eu/index.php/cpe/article/view/3855depressive disordersquality-adjusted life yearswillingness to payquality of lifeelectroconvulsive therapy
spellingShingle Laura Ulbrich
Christoph Kröger
Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study
Clinical Psychology in Europe
depressive disorders
quality-adjusted life years
willingness to pay
quality of life
electroconvulsive therapy
title Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study
title_full Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study
title_fullStr Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study
title_full_unstemmed Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study
title_short Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study
title_sort monetary valuation of a quality adjusted life year qaly for depressive disorders among patients and non patient respondents a matched willingness to pay study
topic depressive disorders
quality-adjusted life years
willingness to pay
quality of life
electroconvulsive therapy
url https://cpe.psychopen.eu/index.php/cpe/article/view/3855
work_keys_str_mv AT lauraulbrich monetaryvaluationofaqualityadjustedlifeyearqalyfordepressivedisordersamongpatientsandnonpatientrespondentsamatchedwillingnesstopaystudy
AT christophkroger monetaryvaluationofaqualityadjustedlifeyearqalyfordepressivedisordersamongpatientsandnonpatientrespondentsamatchedwillingnesstopaystudy